Market Research Report
Global CAR T-cell Therapy Market 2018-2022
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||718255|
|Published||Content info||112 Pages
Delivery time: 1-2 business days
|Global CAR T-cell Therapy Market 2018-2022|
|Published: September 24, 2018||Content info: 112 Pages||
Chimeric antigen receptor (CAR) is one of the recent innovations in the pharmaceutical industry for the treatment of serious, life-threatening diseases, typically in the areas of oncology. CARs are engineered receptors to attack cancer cells. In this therapy, patients' T-cells are modified to attack cancer cells. In this therapy, patients' T-cells are modified in the laboratory to fight against various cancer indications.
Technavio's analysts forecast the Global CAR T-cell Therapy Market to grow at a CAGR of 63.15% during the period 2018-2022.
The report covers the present scenario and the growth prospects of the CAR T-cell therapy market. To calculate the market size, the report considers the revenue generated from the application of CAR T-cell therapy across the globe.
The market is divided into the following segments based on geography:
Technavio's report, CAR T-cell Therapy Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.